Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing High Risk of Bleeding Invasive Procedures

NCT07437755 is registered in ClinicalTrials.gov with Grigore T. Popa University of Medicine and Pharmacy as lead sponsor.

NCT NCT07437755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing High Risk of Bleeding Invasive Procedures
Lead sponsor
Grigore T. Popa University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
October 31, 2026
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis with acute decompensation